Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Articles

Ovarian, fallopian tube or primary peritoneal cancers - Keytruda, Avastin and Cyclophosphamide

Ovarian Cancer – 95% benefit with Keytruda, Avastin and Cyclophosphamide

Background Treatment options for recurrent ovarian cancer are of limited clinical benefit and adversely affect patient quality of life, representing an unmet need for tolerable

Read More »
סרטן הוושט - איקוטיניב פלוס הקרנות

Esophageal cancer at 70 plus? Icotinib plus radiation

Background Concurrent chemoradiation therapy remains the standard therapy for unresectable Esophageal Squamous Cell Carcinoma patients. However, its feasibility and efficiency for older patients are being

Read More »
Debio1143 - Head & Neck Cancer

Head and Neck Cancer – Debio1143 prolonged patient lives

Background 3-year follow-up results from the randomized phase II study assessing the efficacy and safety of Debio 1143 in combination with chemo-radiation therapy vs. chemo-radiation

Read More »

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics